These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2550185)

  • 21. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.
    Xia M; Sreedharan SP; Bolin DR; Gaufo GO; Goetzl EJ
    J Pharmacol Exp Ther; 1997 May; 281(2):629-33. PubMed ID: 9152366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines.
    Zia H; Leyton J; Casibang M; Hau V; Brenneman D; Fridkin M; Gozes I; Moody TW
    Life Sci; 2000; 66(5):379-87. PubMed ID: 10670826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The autocrine regulatory effect of vasoactive intestinal peptide on the growth of human pancreatic carcinoma cells.
    Chen Y; Chen Q; Lu G; Fan Z; Zhong S
    Chin Med Sci J; 1994 Dec; 9(4):215-9. PubMed ID: 7718859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
    Moody TW; Zia F; Draoui M; Brenneman DE; Fridkin M; Davidson A; Gozes I
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4345-9. PubMed ID: 8389448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo.
    Poston GJ; Yao CZ; Upp JR; Alexander RW; Townsend CM; Thompson JC
    Pancreas; 1988; 3(4):439-43. PubMed ID: 3174607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer.
    Raderer M; Kurtaran A; Yang Q; Meghdadi S; Vorbeck F; Hejna M; Angelberger P; Kornek G; Pidlich J; Scheithauer W; Virgolini I
    J Nucl Med; 1998 Sep; 39(9):1570-5. PubMed ID: 9744345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VIP and the skin.
    Lancet; 1991 Apr; 337(8746):886-8. PubMed ID: 1672973
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoregulation of neuroblastoma growth by vasoactive intestinal peptide.
    Pence JC; Shorter NA
    J Pediatr Surg; 1992 Aug; 27(8):935-43; discussion 944. PubMed ID: 1328588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.
    Vacas E; Arenas MI; Muñoz-Moreno L; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Cancer Lett; 2013 Aug; 336(1):196-203. PubMed ID: 23664888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characteristics of the cellular receptor for vasoactive intestinal peptide.
    Goetzl EJ; Hassner A; Cheng PP; Robichon A; Adelman DC; Sreedharan SP
    Trans Assoc Am Physicians; 1991; 104():54-61. PubMed ID: 1668991
    [No Abstract]   [Full Text] [Related]  

  • 34. Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting.
    Rangger C; Helbok A; Ocak M; Radolf T; Andreae F; Virgolini IJ; Von Guggenberg E; Decristoforo C
    Anticancer Res; 2013 Apr; 33(4):1537-46. PubMed ID: 23564795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of vasoactive intestinal polypeptide-receptor-immunoreactivity in human salivary glands.
    Herbst WM; Kummer W; Heym C
    Neuropeptides; 1992 Jun; 22(2):89-92. PubMed ID: 1328922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.
    Ishioka C; Yoshida A; Kimata H; Mikawa H
    Clin Exp Immunol; 1992 Mar; 87(3):504-8. PubMed ID: 1311995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matching localization of vasoactive intestinal polypeptide (VIP) and VIP-receptor at pre- and postsynaptic sites in the mouse visual cortex.
    Csillag A; Hajós F; Zilles K; Schleicher A; Schröder H
    J Neurocytol; 1993 Jun; 22(6):491-7. PubMed ID: 8393920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
    Ravindranathan S; Passang T; Li JM; Wang S; Dhamsania R; Ware MB; Zaidi MY; Zhu J; Cardenas M; Liu Y; Gumber S; Robinson B; Sen-Majumdar A; Zhang H; Chandrakasan S; Kissick H; Frey AB; Thomas SN; El-Rayes BF; Lesinski GB; Waller EK
    Nat Commun; 2022 Oct; 13(1):6418. PubMed ID: 36302761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide stimulates the growth of rat hepatoma cells in vitro.
    Huang X; Zhang Y; Bu Y; Su H
    Chin Med Sci J; 1993 Sep; 8(3):147-50. PubMed ID: 8142629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of tumor cell growth by vasoactive intestinal peptide.
    Scholar EM; Paul S
    Cancer; 1991 Mar; 67(6):1561-4. PubMed ID: 2001545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.